Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia
Clinical trial NCT02175693 · COMPLETED
Trial details
- NCT number
- NCT02175693
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-04-02
- Primary completion
- 2019-06-30
- Enrollment
- 1647
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.